| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |